Scholars Central

Research articlePublished 2015

LC/MS Based Monitoring of Endogenous Decay Markers for Quality Assessment of Serum Specimens

Authors: Jorg Oliver Thumfart, Nada Abidi, Sonani Mindt, Victor Costina, Ralf Hofheinz, Frank Klawonn, Michael Neumaier, Peter Findeisen

Journal of Proteomics & Bioinformatics

Volume 8 · Issue 5 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Preanalytical variations have major impact on most biological assays. Specifically MS-based multiparametric proteomics analyses of blood specimens are seriously affected by limited protein stability due to high intrinsic proteolytic activity of serum and plasma. However, the direct analysis of sample quality (DASQ) for serum specimens is not readily available. Here we propose the mass spectrometry based monitoring of peptide patterns that are ex vivo changing in a time dependent manner to alleviate these constrains. Materials and methods: Serum specimens from healthy controls (n=3) and patients with colorectal cancer were analyzed for a set of endogenous peptides (n=62). The respective proteolytic fragments were monitored with LC/MS at different preanalytical points in time ranging from 1 h to 48 h after blood withdrawal. An algorithm was constructed with a training set of serum specimens from colorectal cancer patients (n=30). An independent test set of patients (n=20) was used for further validation. Results: The coefficient of determination (R2) for the linear regression of true and estimated points in time was 0.89. However, the classification accuracy for specimens with a preanalytical time span below 8 h was higher when compared to older specimens (>8 h). Conclusion: Endogenous peptides are processed in blood specimens in a time dependent manner. This ‘proteomic degradation clock’ can be used to estimate the preanalytical quality of serum specimens. This is specifically relevant prior to in depth proteomic profiling approaches or other laborious analyses in research or diagnostic applications. Accordingly, specimens with low quality can be identified and subsequently be excluded from further analyses to avoid any unwanted preanalytical bias.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Proteomics & Bioinformatics
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Jorg Oliver Thumfart”
  • BylineArticles whose byline prints “Nada Abidi”
  • BylineArticles whose byline prints “Sonani Mindt”
  • BylineArticles whose byline prints “Victor Costina”
  • BylineArticles whose byline prints “Ralf Hofheinz”
  • BylineArticles whose byline prints “Frank Klawonn”
  • BylineArticles whose byline prints “Michael Neumaier”
  • BylineArticles whose byline prints “Peter Findeisen”